山东润泽制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
47
NMPA:47
Drug Approvals
Cefpodoxime Proxetil Tablets
- Product Name
- 头孢泊肟酯片
- Approval Number
- 国药准字H20253331
- Approval Date
- Feb 8, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20247179
- Approval Date
- Aug 1, 2024
NMPA
Cefathiamidine for Injection
- Product Name
- 注射用头孢硫脒
- Approval Number
- 国药准字H20193029
- Approval Date
- Jan 16, 2024
NMPA
Cefathiamidine for Injection
- Product Name
- 注射用头孢硫脒
- Approval Number
- 国药准字H20193030
- Approval Date
- Jan 16, 2024
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20237187
- Approval Date
- Dec 28, 2023
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20237186
- Approval Date
- Dec 28, 2023
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20237060
- Approval Date
- May 31, 2023
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20237059
- Approval Date
- May 31, 2023
NMPA
Latamoxef Sodium for Injection
- Product Name
- 注射用拉氧头孢钠
- Approval Number
- 国药准字H20223710
- Approval Date
- Sep 30, 2022
NMPA
Latamoxef Sodium for Injection
- Product Name
- 注射用拉氧头孢钠
- Approval Number
- 国药准字H20223709
- Approval Date
- Sep 30, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
No trials found
News
No news found